AMBEV S.A. current report, Q4 FY2017

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the month of December 2017, with the report signed on December 8, 2017. The document serves as a report of foreign private issuer transactions pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. It specifically details consolidated transactions of securities issued by the company involving the Board of Directors, Management, and related persons in compliance with Article 11 of CVM Instruction # 358/2002.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to reporting insider trading activity and shareholding balances.

Group Initial Balance (Common Shares) Transactions (Net) Final Balance (Common Shares)
Board of Directors 5,542,123 (6,150) Sold 5,535,973
Management 7,225 0 7,225
Group and Related Persons (Aggregate) 26,651,682 0 26,651,682

Note: The aggregate group balance listed in the second table section appears to include the Board and Management figures, showing no net change for the broader group despite specific Board sales.

Material Changes

The primary material change reported is the sale of 6,150 common shares by members of the Board of Directors during the reporting month. These transactions were executed through various intermediaries (Ágorainvest, XP Investimentos, Itaú Corretora) between November 3 and November 30, 2017, at prices ranging from R$ 20.05 to R$ 20.72 per share, totaling a volume of R$ 124,923.00. No transactions were reported for Management or the Fiscal Council.

Guidance, Outlook, and Risks

The filing text does not provide any guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items. The document is a regulatory disclosure of specific securities transactions and does not contain forward-looking statements.

Investor Verification Checklist

  • Verify the total number of shares sold by the Board of Directors (6,150) against the reduction in their reported holdings.
  • Confirm the transaction dates and prices (R$ 20.05 - R$ 20.72) align with market data for November 2017.
  • Note that the filing explicitly states "In November, 2017" for the transactions, despite the Form 6-K header indicating the report is for the month of December 2017.
  • Check that the aggregate shareholding percentage for the Board decreased slightly from 0.0353% to 0.0352%.